Related Experiment Video
Updated: May 11, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
[Randomized controlled trials terminated prematurely: beneficial therapy effects]
1Klinik für Urologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
Der Urologe. Ausg. A
|May 29, 2013
Summary
Randomized controlled trials (RCTs) stopped early for positive results are common in urology. Understanding potential biases from premature RCT termination is crucial for evidence-based medical practice.
Area of Science:
- Urology
- Clinical Trials
- Evidence-Based Medicine
Background:
- Prematurely terminated randomized controlled trials (RCTs) due to beneficial therapy effects are increasingly frequent in urological research.
- These trials often garner significant attention from the public and medical media.
Purpose of the Study:
- To review the challenges urologists face when interpreting results from RCTs terminated early.
- To highlight the importance of recognizing potential biases associated with early trial cessation.
Main Methods:
- Literature review of prematurely terminated RCTs in urology.
- Analysis of reasons for early termination and their impact on study outcomes.
Main Results:
- Early termination of RCTs can introduce bias, affecting the reliability of reported treatment effects.
- Understanding the methodology and context of early termination is essential for accurate interpretation.
Conclusions:
- Urologists must critically evaluate RCTs stopped early for efficacy.
- Awareness of potential biases is vital for upholding evidence-based medicine principles in clinical practice.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...